R85.614
Cytologic evidence of malignancy on smear of anus
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code R85.614 refers to the presence of malignant cells found during a cytological examination of a sample taken from the anus. This diagnosis indicates that abnormal, potentially cancerous cells have been identified, requiring further medical evaluation and management. Such findings are significant because they can be an early indicator of anal cancer or precancerous conditions. This condition underscores the importance of medical screening and prompt diagnosis to enable appropriate treatment planning.
Causes & Symptoms
Clinical Causes: Persistent infection with human papillomavirus (HPV), especially high-risk strains Chronic immunosuppression, such as in organ transplant recipients or HIV-positive individuals History of anal or other anorectal cancers Anal sexual activity with multiple partners or unprotected intercourse Smoking and other lifestyle factors that increase cancer risk Chronic anal irritation or inflammation
Key Symptoms: Rectal bleeding or blood stains on stool or toilet paper Anal pain, discomfort, or pressure Itching or burning sensation in the anal area A lump or mass near the anus Unusual discharge from the anus Change in bowel habits, such as diarrhea or constipation Feeling of incomplete evacuation
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination, cytological smear tests, and possibly additional procedures such as high-resolution anoscopy, biopsy, or imaging studies. A cytologic smear is performed to collect cells from the anal canal, which are then examined microscopically for malignant features. Confirming the presence of cancer cells usually requires histopathological examination through biopsy, providing definitive diagnosis and informing treatment options.
Treatment Protocols: Treatment approaches depend on the extent and stage of the malignancy and may include a combination of therapies such as surgical removal of abnormal tissue, radiation therapy, and chemotherapy. Early detection through screening can improve treatment outcomes, making timely medical follow-up crucial. Multidisciplinary management often involves specialists in oncology, surgery, and radiology to develop a tailored treatment plan for each patient.
Clinical Advice & FAQs
Billing Guidance
Is R85.614 a billable ICD-10 code?
Yes, R85.614 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R85.614?
Clinical documentation must specify the nature of Cytologic evidence of malignancy on smear of anus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference